Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- The Week in Review: China Deals and Healthcare Stimulus
Nov 29, 2008 01:19 PM
- AOB Has the Herbal Remedy - Analyst Blog
Nov 11, 2008 06:19 PM
- The Week In Review: More Fallout From Economic Crisis
Nov 09, 2008 02:00 PM
- Regeneron a Growth Biotech Play - Analyst Blog
Nov 06, 2008 11:49 AM
- Roche Expanding In Shanghai; Opens Partnership Office
Nov 04, 2008 01:46 PM
- A Bullish Outlook for Generic Drugs After Election
Nov 03, 2008 11:57 PM
- Tongjitang Can Start $20 Million Share Buyback
Nov 03, 2008 01:12 PM
- The Week in Review: Broad Themes And Deals
Oct 25, 2008 04:56 PM
- The Medicines Company (MDCO) - Bull Of The Day
Oct 23, 2008 08:22 AM
- All Wet
Oct 22, 2008 11:24 PM
- NASDAQ OMX and Leerink Swann to Co-Host HealthCare Industry Forum
Dec 04, 2008 09:34 AM
- New Publication Shows Angiomax Significantly Reduces Initial Hospital
Costs by $572 Per Patient Compared to Conventional Therapy in Moderate
and High-Risk ACS Patients
Nov 18, 2008 10:28 AM
- The Medicines Company Reports Third Quarter 2008 Financial Results
Oct 22, 2008 08:23 AM
- Poor Perioperative Blood Pressure Control Linked to 30-Day Morbidity and Mortality in Cardiac Surgery Patients
Oct 21, 2008 08:11 AM
- Angiomax(R) Reduced Cardiac Mortality by 43 Percent and Improved Overall Survival by 31 Percent at One-Year in HORIZONS-AMI Trial
Oct 15, 2008 11:32 AM
- HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients
Oct 15, 2008 11:12 AM
- The Medicines Company Announces HORIZONS-AMI 1-Year Data To Be Presented at 2008 TCT Meeting
Oct 14, 2008 09:46 AM
- The Medicines Company to Announce Third Quarter 2008 Financial Results on Wednesday, October 22, 2008
Oct 08, 2008 05:02 PM
- New Publication Shows Cleviprex(TM) Provides More Precise Blood Pressure Control in Cardiac Surgery Patients
Oct 03, 2008 08:04 AM
- New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
Sep 03, 2008 12:02 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
MDCO
|
Compare to S&P
|
| YTD |
-32.31 %
|
-0.01 %
|
| 4 Weeks |
-25.76 %
|
-12.03 %
|
| 12 Weeks |
-48.45 %
|
-25.63 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -100.00 %
|
|
EPS Growth in Last Year: 100.00 %
|
|
Sales Growth in Last Quarter: 1.61 %
|
|
Sales Growth in Last Quarter: 41.70 %
|
|
|
